Screen 20shot 202014 05 27 20at 204.37.24 20pm
Def 20medical 20technologies 20logo

Synotrac

Implantable device that actively detects infection after joint replacement surgery, saving hospitals money and improving outcomes for patients

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, US
  • Currency USD
  • Founded August 2014
  • Employees 2
  • Incorporation Type C-corp
  • Website synotrac.com

Company Summary

Each year in the US, periprosthetic joint infection (PJI) causes over 40,000 total joint replacements to fail. At a cost of over $100,000 per revision, the annual cost of PJI to the US healthcare system is $4 billion.

Synotrac provides a solution that acts to identify infection at the source and alert the patient in real time. By catching infection in its early stages the device enables treatment with antibiotics rather than surgery.

Team

  • Abe5315d bd7a 4eea 8fb0 eaa4845c5195
    Cofounder and CEO

    Elsa worked at PathSensors, Inc. as Production and Operations Manager, managing, performing, and improving production processes at a biotech startup. Her experience in creating a quality control system and building and optimizing operations will be critical in the construction and testing of the next-stage prototype and company organization.

  • Fe394201 faaa 451d a6fa 473c9592ac42
    Cofounder and CTO

    Forrest identified the unmet need while doing research in orthopedics at Dartmouth. He has experience working as Product Applications and Sales Manager at PathSensors, Inc. where he developed a novel application of the company’s existing technology. His experience both directly in orthopedic research as well as new product development and sales will continue to drive the design of our device, execution of testing, and go-to-market strategy.